| Literature DB >> 14517213 |
Roger A Moorehead1, Carlo V Hojilla, Ian De Belle, Geoffrey A Wood, Jimmie E Fata, Eileen D Adamson, Katrina L M Watson, Dylan R Edwards, Rama Khokha.
Abstract
The tumor suppressor PTEN is altered in many cancers, including breast cancer, but only a handful of factors are known to control its expression. PTEN plays a vital role in cell survival and proliferation by regulating Akt phosphorylation, a key component of the phosphatidylinositol 3 kinase (PI3K) pathway. Here we show that insulin-like growth factor-II (IGF-II), which signals through PI3K, regulates PTEN expression in the mammary gland. IGF-II injection into mouse mammary gland significantly increased PTEN expression. Transgenic IGF-II expression also increased mammary PTEN protein, leading to reductions in Akt phosphorylation, epithelial proliferation, and mammary morphogenesis. IGF-II induced PTEN promoter activity and protein levels and this involved the immediate early gene egr-1. Thus, we have identified a novel negative feedback loop within the PI3K pathway where IGF-II induces PTEN expression to modulate its physiologic effects.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14517213 DOI: 10.1074/jbc.M306894200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157